-
A ranar 21 ga Afrilu, 2026, Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Kasa ta sanar da cewa an nada HS-20093 don allura (risvutatug rezetecan) a matsayin wanda zai yi nasarar samun waraka ga marasa lafiya da ke fama da cutar prostate mai jure castration...Kara karantawa»
-
Kwanan nan, Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kula da Kayayyakin Lafiya ta Kasa (NMPA) ta kasar Sin ta sanar da cewa an amince da Encorafenib na wucin gadi don yin bitar fifiko. Za a yi amfani da shi tare da cetuximab da kuma maganin FOLFOX na chemotherapy a matsayin magani na farko ga...Kara karantawa»
-
Lokacin da kalmomin "ciwon daji na pancreas" suka bayyana a cikin rahoton bincike - musamman idan aka haɗa su da "ciwon hanta guda 25" - iyalai da yawa sun shiga cikin damuwa. Wannan cuta, wacce aka sani da "sarkin ciwon daji," da zarar an gano ta da cizon sauro da yawa, sau da yawa...Kara karantawa»
-
Kwanan nan, Bayer ta sanar da cewa Hukumar Kula da Kayayyakin Lafiya ta Kasa (NMPA) ta amince da sabon maganin sevabertinib da aka yi niyya don maganin manya da ba a iya cirewa ba a cikin gida ko kuma wanda ba a iya cirewa ba a cikin ƙwayoyin huhu (NSCLC) waɗanda ke ɗauke da cutar HER2 (ERBB2) wanda ke kunna ƙwayoyin cuta masu saurin yaɗuwa...Kara karantawa»
-
Ya ku Marasa Lafiya na Ƙasashen Duniya, Idan kai ko ƙaunatattunku kuna fama da cutar kansa kuma kuna neman hanyoyin magani masu sauƙi da inganci, muna so mu gabatar muku da fasahar oncology mai juyin juya hali - Ultrasound Tissue Fragmentation Therapy. An yi nasarar aiwatar da wannan magani mai ci gaba...Kara karantawa»
-
Lokacin da cutar kansa ta mamaye rayuwa, kowace hanyar magani tana da tasiri mai zurfi ga inganci da mutuncin wannan rayuwar. Ga marasa lafiya waɗanda suka tsufa, waɗanda ke da mummunan aikin huhu, ba za su iya jure wa tiyata ko maganin sa barci ba, ko neman hanya mafi sauƙi don yaƙar cutar, ...Kara karantawa»
-
A ranar 31 ga Maris, 2026, Cibiyar Kimanta Magunguna ta Hukumar Kayayyakin Lafiya ta Kasa ta kasar Sin ta bayar da labarai masu kayatarwa: An sanya GFH375, wanda GenFleet Therapeutics ta kirkira, a hukumance a matsayin wanda zai yi maganin marasa lafiya da ke fama da cutar sankarar hanji...Kara karantawa»
-
Ga tsofaffi da yawa masu fama da cutar kansa da iyalansu, ganewar asali sau da yawa yana zuwa da rashin bege. Musamman lokacin da ake fuskantar "sarkin ciwon daji" - ciwon daji na pancreas - tsananin ciwo da rashin iya cin abinci sau da yawa yakan hana marasa lafiya darajarsu, yana barin ƙaunatattunsu cikin mawuyacin hali. Don...Kara karantawa»
-
A ranar 24 ga Maris, 2024, Cibiyar Kimanta Magunguna ta Hukumar Kayayyakin Lafiya ta Kasa ta kasar Sin ta sanar da cewa an gabatar da shawarar sanya sabon maganin Teclistamab a matsayin magani na gaba don magance manyan marasa lafiya da suka sake kamuwa da cutar sankarau ko kuma suka...Kara karantawa»
-
Kwanan nan, Hukumar Kula da Kayayyakin Lafiya ta Ƙasa (NMPA) ta amince da wani sabon magani na Disitamab vedotin na maganin rigakafi (ADC) don magance manyan marasa lafiya da ke fama da cutar kansar nono waɗanda ba za a iya cirewa ko kuma suka kamu da cutar ba (IHC 1+ ko IHC 2+/ISH-) da kuma waɗanda ke da cutar hanta, waɗanda...Kara karantawa»
-
A ranar 10 ga Maris, 2026, sabuwar na'urar hada maganin rigakafi ta B7-H3 (ADC) YL201 don allura, wadda MediLink Therapeutics ta ƙirƙiro, an ba ta izinin naɗa ta Breakthrough Therapy daga Cibiyar Kimanta Magunguna ta Hukumar Kayayyakin Lafiya ta Ƙasa ta China. Wannan na'urar ta nuna...Kara karantawa»
-
Kwanan nan, Cibiyar Nazarin Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Ƙasa ta China ta amince da allurar KSD-101 a hukumance, wadda Kousai ta ƙirƙiro, don shiga gwaje-gwajen asibiti. Wannan ba wai kawai allurar rigakafin ƙwayoyin dendritic na farko ba ne (watsar DC) a China da ta karɓi manhajar FDA IND...Kara karantawa»
Cibiyar likitanci ta haɗin gwiwa ta Asibitin Ciwon Daji na Beijing